Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol. 1963 Jan. 89:37-42. [QxMD MEDLINE Link].
American Cancer Society. Cancer Facts & Figures 2022. American Cancer Society. Available at https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2022/2022-cancer-facts-and-figures.pdf. 2022; Accessed: June 8, 2022.
Lipworth L, Tarone RE, McLaughlin JK. The epidemiology of renal cell carcinoma. J Urol. 2006 Dec. 176(6 Pt 1):2353-8. [QxMD MEDLINE Link].
Sudarshan S, Linehan WM. Genetic basis of cancer of the kidney. Semin Oncol. 2006 Oct. 33(5):544-51. [QxMD MEDLINE Link].
Novick AC, Stewart BH, Straffon RA, Banowsky LH. Partial nephrectomy in the treatment of renal adenocarcinoma. J Urol. 1977 Dec. 118(6):932-6. [QxMD MEDLINE Link].
Huang WC, Atoria CL, Bjurlin M, Pinheiro LC, Russo P, Lowrance WT, et al. Management of Small Kidney Cancers in the New Millennium: Contemporary Trends and Outcomes in a Population-Based Cohort. JAMA Surg. 2015 Jul. 150 (7):664-72. [QxMD MEDLINE Link].
Glazer A, Novick AC. Preoperative transesophageal echocardiography for assessment of vena caval tumor thrombi: a comparative study with venacavography and magnetic resonance imaging. Urology. 1997 Jan. 49(1):32-4. [QxMD MEDLINE Link].
Subramanian VS, Stephenson AJ, Goldfarb DA, Fergany AF, Novick AC, Krishnamurthi V. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology. 2009 Jul. 74(1):154-9. [QxMD MEDLINE Link].
Dechet CB, Sebo T, Farrow G, Blute ML, Engen DE, Zincke H. Prospective analysis of intraoperative frozen needle biopsy of solid renal masses in adults. J Urol. 1999 Oct. 162(4):1282-4; discussion 1284-5. [QxMD MEDLINE Link].
Link RE, Bhayani SB, Allaf ME, et al. Exploring the learning curve, pathological outcomes and perioperative morbidity of laparoscopic partial nephrectomy performed for renal mass. J Urol. 2005 May. 173(5):1690-4. [QxMD MEDLINE Link].
Antonelli A, Cozzoli A, Simeone C, et al. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients. BJU Int. 2006 Mar. 97(3):505-8. [QxMD MEDLINE Link].
Yokoyama H, Tanaka M. Incidence of adrenal involvement and assessing adrenal function in patients with renal cell carcinoma: is ipsilateral adrenalectomy indispensable during radical nephrectomy?. BJU Int. 2005 Mar. 95(4):526-9. [QxMD MEDLINE Link].
Bianchi M, Gandaglia G, Trinh QD, Hansen J, Becker A, Abdollah F, et al. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma. Urol Oncol. 2013 Sep 17. [QxMD MEDLINE Link].
Golimbu M, Joshi P, Sperber A, Tessler A, Al-Askari S, Morales P. Renal cell carcinoma: survival and prognostic factors. Urology. 1986 Apr. 27(4):291-301. [QxMD MEDLINE Link].
Morgan TM, Mehra R, Tiemeny P, Wolf JS, Wu S, Sangale Z, et al. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma. Eur Urol. 2018 May. 73 (5):763-769. [QxMD MEDLINE Link].
Oh JJ, Byun SS, Lee SE, Hong SK, Lee ES, Kim HH, et al. Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: A multi-institutional comparative analysis. Int J Urol. 2013 Sep 30. [QxMD MEDLINE Link].
Kim SP, Thompson RH, Boorjian SA, Weight CJ, Han LC, Murad MH, et al. Comparative effectiveness for survival and renal function of partial and radical nephrectomy for localized renal tumors: a systematic review and meta-analysis. J Urol. 2012 Jul. 188(1):51-7. [QxMD MEDLINE Link].
Emara A, Kommu S, Hindley R, Barber N. Robotic Partial Nephrectomy versus Laparoscopic Guided Cryoablation for the Small Renal Mass: redefining the minimally invasive gold standard. BJU Int. 2013 May 23. [QxMD MEDLINE Link].
Romao RL, Weber B, Gerstle JT, Grant R, Pippi Salle JL, Bägli DJ, et al. Comparison between laparoscopic and open radical nephrectomy for the treatment of primary renal tumors in children: single-center experience over a 5-year period. J Pediatr Urol. 2014 Jun. 10 (3):488-94. [QxMD MEDLINE Link].
Hegarty NJ, Gill IS, Desai MM, Remer EM, O'Malley CM, Kaouk JH. Probe-ablative nephron-sparing surgery: cryoablation versus radiofrequency ablation. Urology. 2006 Jul. 68(1 Suppl):7-13. [QxMD MEDLINE Link].
Kaouk JH, Aron M, Rewcastle JC, Gill IS. Cryotherapy: clinical end points and their experimental foundations. Urology. 2006 Jul. 68(1 Suppl):38-44. [QxMD MEDLINE Link].
Al-Qudah HS, Rodriguez AR, Sexton WJ. Laparoscopic management of kidney cancer: updated review. Cancer Control. 2007 Jul. 14(3):218-30. [QxMD MEDLINE Link]. [Full Text].
Atwell TD, Farrell MA, Leibovich BC, Callstrom MR, Chow GK, Blute ML. Percutaneous renal cryoablation: experience treating 115 tumors. J Urol. 2008 Jun. 179(6):2136-40; discussion 2140-1. [QxMD MEDLINE Link].
Clayman RV, Surya V, Miller RP, Reinke DB, Fraley EE. Pursuit of the renal mass. Is ultrasound enough?. Am J Med. 1984 Aug. 77(2):218-23. [QxMD MEDLINE Link].
Cookson MS. Radical Nephrectomy. Graham Jr SD, Glenn JF, eds. Glenn's Urologic Surgery. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998. 61-72.
Cooney MM, Remick SC, Vogelzang NJ. Promising systemic therapy for renal cell carcinoma. Curr Treat Options Oncol. 2005 Sep. 6(5):357-65. [QxMD MEDLINE Link].
Desai MM, Strzempkowski B, Matin SF, et al. Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy. J Urol. 2005 Jan. 173(1):38-41. [QxMD MEDLINE Link].
Finley DS, Beck S, Box G, Chu W, Deane L, Vajgrt DJ. Percutaneous and laparoscopic cryoablation of small renal masses. J Urol. 2008 Aug. 180(2):492-8; discussion 498. [QxMD MEDLINE Link].
Flaherty KT, Fuchs CS, Colditz GA, et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control. 2005 Nov. 16(9):1099-106. [QxMD MEDLINE Link].